COYA
Coya Therapeutics, Inc.
5.10$
-1.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | -186.4% | -289.5% | -135.2% | |
| – | – | – | 0.5% | 0.8% | 0.3% | |
| – | – | – | 14.5% | 74.9% | 54.0% | |
| – | – | – | -77.4% | 52.8% | 48.8% | |
| – | – | – | 0.0% | 0.0% | 0.0% | |
| – | – | – | -9.0% | -0.7% | -14.7% | |
| – | – | – | 0.0% | – | – | |
| – | – | – | 640.2% | 450.9% | 256.6% | |
| – | – | – | 444.7% | 160.7% | 106.8% | |
| – | – | – | -186.4% | -289.5% | -135.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.